Director, Image Analysis, Translational Pathology

Join a Legacy of Innovation 125 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 125 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 18,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

Job Summary:

The Director, Image Analysis, Translational Pathology will work across the Precision Medicine matrix contributing to the development of digital and computational pathology strategy and implementation of digital pathology-based approaches to assessing potential predictive (patient selection) biomarkers as well as pharmacodynamic (PD) biomarkers for Oncology and Specialty Medicine programs. They will serve as a scientific expert supporting digital/computational pathology objectives including assessment of imaging technologies and platforms, algorithm development for pre-clinical, translational, and CDx use, and image analysis data generation and interpretation. They will provide expertise to create and integrate pathology datasets with broader multi-omic analyses to support hypothesis-driven translational research efforts with direct impact across the development continuum.

Responsibilities:

• Provide expertise for the Translational Pathology group and lead image analysis algorithm development and decisions for digital pathology investigations performed internally and as a point of contact with external partners.

• Design and lead whole-slide scanning and image storage evaluations and decisions for Translational Pathology, analyze and interpret image data, and serve as a scientific expert for the design and implementation of translational pathology plans that include digital imaging data.

• Contribute to the development of company-wide computational pathology strategy and implementation through leadership of image analysis foundational platform capabilities, algorithm development and optimization, and external partnerships for biomarker discovery

• Provide expertise to the Daiichi Sankyo Global Research Development organization to ensure access to state-of-the-art thinking on appropriate imaging analysis strategies, evaluating their scientific basis and clinical applicability, the validation status and any technical or statistical issues related to proposed business plans.

Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

Education:

• Bachelor's degree (BS) in biology, biotechnology, biomedical engineering, or related field required

• PhD in biology, biotechnology, biomedical engineering, or related field or Master's degree (MS) in biology, biotechnology, biomedical engineering, or related field preferred

Experience:

• 10 or more years of digital imaging analysis, or other relevant experience with bachelor's degree OR 5 or more years of digital imaging analysis, or other relevant experience with PhD required.

• Hands on experience with digital/computational pathology technologies, algorithm development, and translational research required.

• Experience with image analysis software and slide scanning technologies and deep knowledge in pathology-based and other biomarker technologies including immunohistochemistry (monoplex and multiplex), digital pathology, and spatial analyses required

• Experience with image analysis software and slide scanning technologies required

• Experience/knowledge in companion diagnostics device development preferred

Travel:

• Ability to travel up to 10% globally

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.